Leadership Overview
Accupac has 4 executives leading key functions including strategy, operations, finance, and human capital.
Driven by a commitment to excellence, Accupac provides outsourced manufacturing and packaging solutions, focusing on pharmaceutical and personal care products to enhance market reach and product integrity.
Driven by a commitment to excellence, Accupac provides outsourced manufacturing and packaging solutions, focusing on pharmaceutical and personal care products to enhance market reach and product integrity.
Leadership Roles at Accupac
Edward Gotch - Chief Executive Officer
Edward Gotch, the Chief Executive Officer at Accupac, directs the overarching corporate strategy and long-term vision. Overseeing all major business units, Gotch ensures operational alignment with market demands for pharmaceutical and personal care manufacturing. This leadership role involves driving innovation in packaging solutions and expanding service offerings to meet evolving client needs. By fostering strategic partnerships, Edward Gotch strengthens Accupac's position as a premier outsourced manufacturing provider. The Chief Executive Officer's focus remains on sustainable growth and enhancing shareholder value through meticulous execution of business objectives.
Paul Alvater - President & Chief Executive Officer
Paul Alvater, the President & Chief Executive Officer at Accupac, spearheads the company's operational execution and market expansion initiatives. Alvater guides the integration of advanced manufacturing technologies to optimize production workflows for pharmaceutical and personal care products. This executive position involves direct oversight of client relations and ensuring service delivery meets stringent industry standards. By championing efficiency improvements, Paul Alvater drives profitability and reinforces Accupac's reputation for reliability. The President & Chief Executive Officer's strategic direction ensures the company maintains its competitive edge in outsourced packaging and manufacturing services.
Joseph Warchol - Chief Financial Officer
Joseph Warchol, the Chief Financial Officer at Accupac, manages all financial operations and fiscal strategy. Warchol oversees budgeting, forecasting, and financial reporting, ensuring robust fiscal health for the organization. This critical role involves optimizing capital allocation and managing financial risks associated with manufacturing and packaging services for pharmaceutical and personal care sectors. By implementing stringent financial controls, Joseph Warchol supports Accupac's growth objectives and enhances investor confidence. The Chief Financial Officer's expertise is vital in navigating market fluctuations and securing resources for strategic investments and operational enhancements.
Katherine Gillespie - Chief Human Resources Officer
Katherine Gillespie, the Chief Human Resources Officer at Accupac, leads talent acquisition, development, and organizational culture initiatives. Gillespie designs and implements HR strategies that support Accupac's mission of providing specialized manufacturing and packaging solutions. This executive function focuses on cultivating a skilled workforce capable of meeting the rigorous demands of the pharmaceutical and personal care industries. By fostering employee engagement and ensuring compliance with labor regulations, Katherine Gillespie contributes to operational stability and efficiency. The Chief Human Resources Officer's efforts are instrumental in attracting and retaining top talent, driving the company's overall success.
Explore Leadership Teams in Manufacturing
Sandoz Group AG (SIX: SDZ) is a global healthcare company focused on developing, manufacturing, and delivering high-quality generic medicines and biosimilars. Serving patients worldwide, Sandoz provides treatments across multiple therapeutic areas, including oncology, immunology, and cardiovascular health.
Company Leadership AJ
SA
MN
MH
Founded in 1989, Macleods Pharmaceutical develops and manufactures generic pharmaceuticals. The Company offers tablets, drugs, syrup, and other related products. The company is headquartered in Mumbai, Maharashtra, India.
Company Leadership JV
SP
AM
ANI Pharmaceuticals, Inc. is a diversified bio-pharmaceutical company serving patients in need by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceutical products. Our team is focused on delivering sustainable growth by building a successful Purified Cortrophin Gel franchise, strengthening our generics business with enhanced development capability, innovation in established brands and leveraging our North American manufacturing capabilities.
Company Leadership NL
MP
MS
SS
Eisai Co., Ltd. offers pharmaceutical products in Japan. It offers Aricept for the treatment of alzheimer's disease/dementia with Lewy bodies; Methycobal for the treatment of peripheral neuropathy; and Fycompa, an antiepileptic drug for the adjunctive treatment of partial-onset and primary generalized tonic-clonic seizures. The company also provides Lyrica for pain treatment; Dayvigo, an anti-insomnia drug for the treatment of adults with insomnia; Lenvima, an anticancer agent/molecular targeted medicine for the treatment of thyroid cancer, renal cell carcinoma in combination with everolimus, and hepatocellular carcinoma; and Halaven, an anticancer agent/microtubule dynamics inhibitor for the treatment of breast cancer and liposarcoma. In addition, it offers Pariet, a proton-pump inhibitor for the treatment of gastric and duodenal ulcers, reflux esophagitis, and eradication of Helicobacter pylori infections, etc.; Humira, a fully human anti-TNF-a monoclonal antibody for the treatment of autoimmune diseases, such as rheumatoid arthritis; and Chocola BB plus, a vitamin B2 preparation for rough skin and stomatitis, as well as various products, which include third-class OTC drugs, designated quasi-drugs, and food with nutrient function. The company was formerly known as Nihon Eisai Co., Ltd. and changed its name to Eisai Co., Ltd. in 1955. Eisai Co., Ltd. was incorporated in 1941 and is headquartered in Tokyo, Japan.
Company Leadership TI
SG
SP
CS